Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic medication that works by blocking muscarinic receptors. It acts primarily on the smooth muscle of the gastrointestinal tract, reducing spasms and cramping. It has limited systemic absorption when taken orally, and its quaternary ammonium structure prevents it from readily crossing the blood-brain barrier, thus minimizing central anticholinergic effects.
## Primary Indications
* Symptomatic relief of abdominal cramping and spasms associated with Irritable Bowel Syndrome (IBS).
* Relief of acute abdominal pain due to gastrointestinal spasms.
## Adult Dosing
* **Oral:** 10 mg three to five times daily. Maximum dose: 100 mg daily.
* **Parenteral (IM/IV):** 20 mg every 6-8 hours as needed. Maximum dose: 100 mg daily.
## Pediatric Dosing
Dosing in children is less established and should be guided by clinical judgment and local protocols.
* **Oral:** Generally not recommended for routine use in children under 12 years. If used, doses are typically lower than adult doses and often require physician supervision.
* **Parenteral (IM/IV):** Generally not recommended for routine use in children. Use with caution and at lower doses than adults, under strict medical supervision.
## Dose Adjustments
No dose adjustment is typically required for hepatic or renal impairment, given limited systemic absorption and metabolism.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Glaucoma (angle-closure).
* Tachyarrhythmias.
* Ileus or intestinal obstruction.
* Megacolon.
* Prostatic hypertrophy with urinary retention.
* Cystic fibrosis (increased risk of adverse effects).
## Adverse Effects
Common: dry mouth, blurred vision, constipation, tachycardia, urinary retention, decreased sweating. Less common: allergic reactions, dizziness, drowsiness.
## Key Drug Interactions
* **Other anticholinergics (e.g., tricyclic antidepressants, antihistamines, antipsychotics):** Increased risk of additive anticholinergic effects.
* **Dopamine antagonists (e.g., metoclopramide):** May reduce the efficacy of both drugs.
* **Beta-blockers:** May increase heart rate due to opposing effects.
## Monitoring
* Monitor for resolution of abdominal symptoms.
* Assess for signs of anticholinergic adverse effects, especially in elderly patients.
* Monitor urine output, particularly in patients with a history of urinary retention.
## Clinical Pearls
* Oral formulations are poorly absorbed systemically, making them generally safer for long-term use with fewer systemic side effects.
* Parenteral administration provides more rapid and potent antispasmodic effects but carries a higher risk of systemic anticholinergic adverse effects.
* Effectiveness for chronic pain or severe spasms may be limited.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace comprehensive drug information resources. Always consult current prescribing information and relevant guidelines before administering any medication. Dosing may vary based on patient-specific factors and local protocols.
